Tci Wealth Advisors, Inc. Spring Works Therapeutics, Inc. Transaction History

Tci Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	BUY	$18.36 - $60.07 $1,266 - $4,144	69 Added 109.52%	132 $3,000
Q1 2022 Apr 29, 2022	SELL	$48.97 - $65.46 $3,770 - $5,040	-77 Reduced 55.0%	63 $4,000
Q4 2021 Jan 24, 2022	BUY	$53.3 - $75.84 $4,690 - $6,673	88 Added 169.23%	140 $9,000
Q3 2021 Oct 29, 2021	SELL	$62.66 - $88.26 $1,817 - $2,559	-29 Reduced 35.8%	52 $3,000
Q2 2021 Aug 02, 2021	BUY	$67.45 - $85.63 $2,967 - $3,767	44 Added 118.92%	81 $7,000
Q1 2021 Apr 29, 2021	BUY	$65.1 - $93.59 $2,408 - $3,462	37 New	37 $3,000

220

66.8M

64.7K

150K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $1.87B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.